<body class=

About admin

This author has not yet filled in any details.
So far admin has created 17 blog entries.

Promising Practice Alert! – My Questions

Continue your focus on Shared Decision Making by encouraging your patients to be a part of their healthcare team.  Patient engagement in the Plan of Care is one way to encourage patients to take part in Shared Decision Making. The Network has developed the “Do You Have Questions About Your Dialysis?” flyer to help patients

By | September 17th, 2019|Uncategorized|0 Comments

Public Comment Period for CY 2020 ESRD PPS Proposed Rule Closing Soon

On July 29, 2019 the Centers for Medicare & Medicaid Services (CMS) announced the public display of the proposed rule for the CY 2020 ESRD Prospective Payment System (PPS), available online at the Federal Register. The CY 2020 ESRD PPS proposed rule includes proposed requirements for the ESRD Quality Incentive Program (ESRD QIP) beginning with Payment

By | September 17th, 2019|Uncategorized|Comments Off on Public Comment Period for CY 2020 ESRD PPS Proposed Rule Closing Soon

NHSN Data – Due Sept. 30

To meet the CMS ESRD QIP NHSN reporting requirements for Payment Year 2021, outpatient hemodialysis clinics must submit their second quarter 2019 Dialysis Event data collected from April 1st, 2019 through June 30th, 2019, by Monday, September 30, 2019. New or revised second quarter data entered into NHSN after September 30th will not be sent to

By | September 17th, 2019|Uncategorized|Comments Off on NHSN Data – Due Sept. 30

Promising Practice Alert

Have you been struggling to find a way to include the Patient Voice in your QAPI meetings? The Network encourages you to invite patients to your monthly quality meetings. In order to get patients involved, you must educate them about the purpose of the meeting. We’ve created this QAPI Patient Invitation to do just that!

By | September 17th, 2019|Uncategorized|Comments Off on Promising Practice Alert

ESRD Medicare Timeline

Medicare Entitlement and 30 Month Coordination Period Begins Medicare starts on first day of fourth month of Hemodialysis Medicare goes back to 1st day of month that Peritoneal Dialysis began Medicare goes back to 1st day of month that kidney transplant is received Medicare pays after your insurance does, it pays deductibles and copays Medicare

By | September 16th, 2019|Uncategorized|Comments Off on ESRD Medicare Timeline

Medicare Part D – Medicare Drug Plans

Medicare prescription drug coverage is an optional benefit offered to everyone who has Medicare. If you decide not to get Medicare Part D when you’re first eligible, you will likely pay a late enrollment penalty if you join later. There are two ways you can get drug coverage: Medicare Prescription Drug Plan (Part D). These

By | September 16th, 2019|Medicare Part D|Comments Off on Medicare Part D – Medicare Drug Plans

Fresenius Kabi Recalls Volumat MC Agilia Infusion Pump and Vigilant Agilia Drug Library

The FDA has identified this as a Class I recall, the most serious type of recall.  Use of these devices may cause serious injuries or death. Recalled Product Volumat MC Agilia Infusion System and Vigilant Drug LibraryModelsVolumat MC Agilia Z021135, Software Versions 1.7 and 1.9aVigilant Drug Library Z073476, Software Versions 1.0 and 1.1Lot Numbers: AllManufacturing

By | August 15th, 2019|alerts|0 Comments

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection

Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level. One vial of product was observed containing a glass fragment after reconstitution. The administration of a glass particulate, if present in an intravenous

By | May 8th, 2019|alerts|0 Comments

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s

By | December 3rd, 2018|alerts|0 Comments